Physician profile
Jon Scott Stancil
NPI 1740241355
$9,065.59
in general payments reported to CMS, 2019-2025
45 companies · $1,179 in 2025
The $1,179 reported for 2025 was more than what 88% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $905 · 2020: $831 · 2021: $571 · 2022: $1,270 · 2023: $800 · 2024: $3,509 · 2025: $1,179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,695 · Travel and Lodging: $1,793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,695.03 |
| Travel and Lodging | $1,793.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $2,687.00 | 2024-2025 | |
| Tricoast Surgical Solutions LLC | $841.11 | 2022-2025 | |
| Organogenesis INC. | $771.50 | 2019-2024 | Puraply |
| Smith+Nephew, INC. | $726.19 | 2019-2025 | Grafix Pl, Stravix, Stravix Pl |
| Arthrex, INC. | $498.95 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $403.82 | 2021-2025 | Nuzyra |
| Kerecis Limited | $362.57 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Amgen INC. | $353.96 | 2024-2025 | Krystexxa |
| Horizon Therapeutics Plc | $302.85 | 2021-2023 | Krystexxa |
| Janssen Pharmaceuticals, INC | $277.52 | 2022 | |
| Zimmer Biomet Holdings, INC. | $258.75 | 2019-2025 | Tapestry |
| Depuy Synthes Sales INC. | $187.25 | 2021-2024 | Vivigen Mis Delivery System, Minibunion, Motoband |
| Abbvie INC. | $138.18 | 2023-2025 | Dalvance |
| Kci USA, INC. | $129.55 | 2019-2021 | |
| Osiris Therapeutics INC. | $104.18 | 2019 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Triad Life Sciences INC. | $91.46 | 2022 | |
| Medtronic, INC. | $84.33 | 2024 | Intellis Adaptivestim |
| Melinta Therapeutics, LLC | $67.73 | 2019-2022 | |
| Stryker Corporation | $65.60 | 2020 | |
| Nevro Corp. | $60.77 | 2022-2023 | Senza |
| Kowa Pharmaceuticals America, INC. | $59.61 | 2023 | Seglentis |
| Solventum Corporation | $48.56 | 2024-2025 | Activ.A.C., Prevena, V.A.C. Veraflo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $45.14 | 2020 | |
| Aroa Biosurgery Incorporated | $40.93 | 2025 | |
| Paragon 28, INC. | $40.62 | 2024 | Precision Guide Lapidus |
| Zyla Life Sciences, INC. | $40.46 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $36.25 | 2019 | |
| Polarityte, INC. | $33.50 | 2019-2020 | |
| Integra Lifesciences Corporation | $25.48 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $24.22 | 2021 | |
| Biocomposites INC | $23.83 | 2025 | Stimulan |
| Vertex Pharmaceuticals Incorporated | $23.46 | 2025 | |
| Nabriva Therapeutics, Plc | $23.40 | 2021-2022 | |
| Hydrofera LLC | $18.72 | 2021 | |
| Arbor Pharmaceuticals, INC. | $18.18 | 2019 | |
| Globus Medical, INC. | $17.54 | 2025 | Senza |
| Zimvie INC. | $16.51 | 2023 | |
| Convatec INC. | $16.24 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $15.19 | 2019 | |
| Baxter Healthcare | $14.90 | 2021 | |
| Next Science LLC | $14.71 | 2023 | Blastx, Surgx, Xperience |
| Highridge Medical LLC | $14.54 | 2024 | Biomet Ebi Bone Healing System |
| Urgo Medical North America, LLC | $14.17 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Bioventus LLC | $13.87 | 2020 | |
| Grt US Holding, INC. | $12.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Stancil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.